# Tranexamic Acid Versus Misoprostol to Reduce Blood Loss During and After Cesarean Section

> **NCT07712510** · PHASE4 · COMPLETED · sponsor: **Medicare Hospital (Pvt) Limited** · enrollment: 214 (actual)

## Conditions studied

- Blood Loss, Surgical
- Blood Loss, Postoperative
- Cesarean Section

## Interventions

- **DRUG:** Intravenous Tranexamic Acid
- **DRUG:** rectal misoprostol

## Key facts

- **NCT ID:** NCT07712510
- **Lead sponsor:** Medicare Hospital (Pvt) Limited
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-01
- **Primary completion:** 2025-08-30
- **Final completion:** 2025-08-30
- **Target enrollment:** 214 (ACTUAL)
- **Last updated:** 2026-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07712510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07712510, "Tranexamic Acid Versus Misoprostol to Reduce Blood Loss During and After Cesarean Section". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07712510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*